Joakim Bo Kunkel

Joakim Bo Kunkel

Auto-generated profile, based on publicly available information

Joakim Bo Kunkel

Rigshospitalet - Copenhagen University Hospital, Department of Cardiology , Copenhagen

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2023 in European Heart Journal: Acute Cardiovascular Care
Verified
Journal Article
Closed access
PDF file
JKJoakim Bo Kunkel
Joakim Bo Kunkel
JJJakob Josiassen
Jakob Josiassen
OHOle Kristian Lerche Helgestad
Ole Kristian Lerche Helgestad
HSHenrik Schmidt
Henrik Schmidt
LHLene Holmvang
Lene Holmvang
CHChristian Hassager
Christian Hassager
Cardiogenic shock (CS) is known to induce an inflammatory response. The prognostic utility of this remains unclear. To investigate the association between C-reactive protein (CRP) levels and leucocyte count and mortality in patients with acute myocardial infarction complicated by CS (AMICS). Consecutive patients (N = 1716) admitted between 2010 and 2017 with an individually validated diagnosis of AMICS were included. The analysis was restricted to patients alive at 48 h after first medical contact and a valid CRP and leucocyte measurement at 48 ± 12 h from the first medical contact. A combined inflammatory score for each patient was computed by summing the CRP and leucocyte count z-scores to normalize the response on a standard deviation scale. Associations with mortality were analysed using a multivariable Cox proportional hazards model stratified by inflammatory response quartiles: Of the 1716 patients in the cohort, 1111 (64.7%) fulfilled inclusion criteria. The median CRP level at 48 h was 145 mg/dL [interquartile range (IQR) 96–211]. The median leucocyte count was 12.6 × 10−9/L (IQR 10.1–16.4). Patients with the highest inflammatory response (Q4) had lower median left ventricular ejection fractions and higher lactate levels at the time of diagnosis. The 30-day all-cause mortality rates were 46% in Q4 and 21% in Q1 (P < 0.001). In multivariable models, the inflammatory response remained associated with mortality [hazard ratio (HR)Q4 2.32, 95% confidence interval (CI) 1.59–3.39, P < 0.001]. The finding was also significant in AMICS patients presenting with out-of-hospital cardiac arrest following multivariable adjustment (HRQ4 3.37, 95% CI 2.02–4.64, P < 0.001). Cardiogenic shock induces an acute inflammatory response, the severity of which is associated with mortality.

5 November 2024 in Trials
Verified
Journal Article
Open access
PDF file
JKJoakim Bo Kunkel
Joakim Bo Kunkel
SHSarah Louise Duus Holle
Sarah Louise Duus Holle
CHChristian Hassager
Christian Hassager
RPRedi Pecini
Redi Pecini
SWSebastian Wiberg
Sebastian Wiberg
HSHelle Søholm
Helle Søholm
Background: Inflammation and neurohormonal activation play a significant role in the adverse outcome seen in acute myocardial infarction (AMI) and the development of cardiogenic shock (CS), which is associated with a mortality rate up to 50%. Treatment with anti-inflammatory drugs such as tocilizumab, an interleukin-6 receptor antagonist, has been shown to reduce troponin release and reduce the myocardial infarct size in AMI patients and it may therefore have cardioprotective properties. Methods: This is a double-blind, placebo-controlled, single-center randomized clinical trial, including adult AMI patients without CS at hospital arrival, undergoing percutaneous coronary intervention (PCI) within 24 h from symptom onset, and at intermediate to high risk of developing CS (ORBI risk score ≥ 10). A total of 100 participants will be randomized to receive a single intravenous dose of tocilizumab (280 mg) or placebo (normal saline). The primary outcome is peak plasma pro-B-type natriuretic peptide (proBNP) within 48 h, assessed using serial measurements at intervals: before infusion, 12, 24, 36, and 48 h after infusion. Secondary endpoints include the following: (1) cardiac magnetic resonance imaging (CMR) during 24–48 h after admission and at follow-up after 3 months with assessment of left ventricular area at risk, final infarct size, and the derived salvage index and (2) biochemical markers of inflammation (C-reactive protein and leukocyte counts) and cardiac injury (troponin T and creatinine kinase MB). Discussion: Modulation of interleukin-6-mediated inflammation in patients with AMI, treated with acute PCI, and at intermediate to high risk of in-hospital CS may lead to increased hemodynamic stability and reduced left ventricular infarct size, which will be assessed using blood biomarkers with proBNP as the primary outcome and inflammatory markers, troponin T, and CMR with myocardial salvage index as the secondary endpoints. Trial registration: Registered with the Regional Ethics Committee (H-21045751), EudraCT (2021–002028-19), ClinicalTrials.gov (NCT05350592). Study registration date: 2022-03-08, Universal Trial Number U1111-1277–8523.

12 March 2024 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
KMKatrine Aagaard Myhr
Katrine Aagaard Myhr
LALiv Andrés-Jensen
Liv Andrés-Jensen
BLBjørn Strøier Larsen
Bjørn Strøier Larsen
JKJoakim Bo Kunkel
Joakim Bo Kunkel
CKCharlotte Kristensen
Charlotte Kristensen
RPRedi Pecini
Redi Pecini
Aims: Cardiovascular diseases manifest differently in males and females, potentially influenced by inherent sex- and age-related differences in myocardial tissue composition. Such inherent differences are not well-established in the literature. With this study using cardiac magnetic resonance (CMR) native T1 mapping, we aim to determine the effect of sex and age on myocardial tissue composition in healthy individuals. Methods and results: CMR native T1 mapping was performed in 276 healthy individuals (55% male, age 8­­–84 years) on a 1.5 Tesla scanner using a MOLLI 5(3)3 acquisition scheme. Additionally, 30 healthy participants (47% male, age 24–68 years) underwent a 1-year follow-up CMR to assess the longitudinal changes of native T1. Mean native T1 values were 1000 ± 22 ms in males and 1022 ± 23 ms in females [mean difference (MD) = 22 ms, 95% confidence interval (CI) (17, 27)]. Female sex was associated with higher native T1 in multivariable linear regression adjusting for age, heart rate, left ventricular mass index, and blood T1 [β=10 ms, 95% CI (3.4, 15.8)]. There was no significant interaction between sex and age (P = 0.27). Further, age was not associated with native T1 [β=0.1 ms, 95% CI (−0.02, 0.2)], and native T1 did not change during a 1-year period [MD −4 ms, 95% CI (−11, 3)]. Conclusion: Female sex was associated with higher native T1; however, there was no association between age and native T1. Additionally, there was no evidence of an interaction between sex and age. Our findings indicate intrinsic sex-based disparities in myocardial tissue composition.

5 November 2026 in New England Journal of Medicine
Verified
Journal Article
Closed access
HBHenning Bundgaard
Henning Bundgaard
IGInés García-Lunar
Inés García-Lunar
KKKlaus F. Kofoed
Klaus F. Kofoed
RHRasmus Hasselbalch
Rasmus Hasselbalch
CPCarlos Nicolás Pérez-García
Carlos Nicolás Pérez-García
BIBorja Ibanez
Borja Ibanez

8 March 2026 in JACC
Verified
Journal Article
Closed access
JKJoakim Bo Kunkel
Joakim Bo Kunkel
SHSarah Louise Duus Holle
Sarah Louise Duus Holle
CHChristian Hassager
Christian Hassager
RPRedi Pecini
Redi Pecini
SWSebastian Wiberg
Sebastian Wiberg
HSHelle Søholm
Helle Søholm

20 September 2025 in British Journal of Anaesthesia
Verified
Journal Article
Open access
SWSebastian Wiberg
Sebastian Wiberg
CMChristian H. Møller
Christian H. Møller
JKJesper Kjaergaard
Jesper Kjaergaard
AMAstrid D. Mikkelsen
Astrid D. Mikkelsen
HMHasse Møller-Sørensen
Hasse Møller-Sørensen
JNJens C. Nilsson
Jens C. Nilsson
Maintaining adequate oxygen delivery during cardiopulmonary bypass (CPB)-assisted cardiac surgery is crucial, but hyperoxia has been suggested to cause organ injury. We compared the effects of restrictive vs liberal oxygenation during CPB and weaning from CPB on clinical outcomes in cardiac surgery. We conducted a single-centre, patient- and assessor-blinded randomised trial on adults undergoing CPB-assisted coronary artery bypass grafting, aortic valve replacement, or both. Participants were randomly assigned (1:1) to restrictive (Fio2=50%) or liberal (Fio2=100%) oxygen therapy during and for the first hour after weaning from CPB. The primary composite outcome was the time to death, stroke, renal failure requiring dialysis, or new-onset or worsening heart failure during follow-up. Among 1389 participants (mean age, 67 yr [range, 29-85 yr]; 17% female), randomisation to receive Fio2 50% resulted in median Pao2 levels of 19-23 kPa during CPB, compared with >60 kPa in participants receiving Fio2 100%. During a median follow-up period of 5.9 yr (interquartile range, 2.5-8.3), 167/695 (24%) participants in the restrictive oxygenation group and 168/694 (24%) participants in the liberal oxygenation group met the primary endpoint (hazard ratio, 1.01 [95% confidence interval, 0.8-1.3]; P=0.92). There was no difference in adverse event rates between restrictive and liberal oxygen therapy. Among patients undergoing elective or urgent CPB-assisted coronary artery bypass grafting, aortic valve replacement, or both, no significant differences were observed in mortality, dialysis-dependent renal failure, stroke, or new-onset or worsening heart failure between a restrictive oxygenation strategy (Fio2 50%) and a liberal oxygenation strategy (Fio2 100%) during CPB and the subsequent weaning period. NCT02673931.